论文部分内容阅读
目的探讨依达拉奉联合银杏达莫治疗急性心肌梗死的临床疗效。方法选取灵寿县中西医结合医院2016年收治的急性脑梗死患者130例,随机分为观察组和对照组,各65例。入院后患者均给予常规药物治疗,观察组患者给予依达拉奉联合银杏达莫治疗,对照组患者给予依达拉奉治疗,两组患者的疗程均为2周。比较两组患者的临床疗效及神经功能改善情况,并密切关注患者不良反应发生情况。结果观察组患者治疗总有效率高于对照组(P<0.05)。治疗前,两组患者神经功能缺损情况比较,差异无统计学意义(P>0.05);观察组患者药物治疗2周后的神经功能缺损情况显著改善,且改善情况优于对照组(P<0.05)。观察组患者不良反应发生率低于对照组(P<0.05)。结论在常规药物治疗的基础上,对急性脑梗死患者采用依达拉奉联合银杏达莫治疗是一种可行、有效、经济的治疗方法,临床疗效确切,可有效改善患者的神经功能,且安全性高。
Objective To investigate the clinical efficacy of edaravone combined with ginkgo biloba in the treatment of acute myocardial infarction. Methods 130 patients with acute cerebral infarction admitted to Integrative Medicine Hospital of Lingshou County in 2016 were randomly divided into observation group and control group, 65 cases each. All patients were given conventional medication after admission. Patients in the observation group were treated with edaravone and ginkgo biloba, while those in the control group were treated with edaravone. Both groups were treated for 2 weeks. The clinical efficacy and neurological function of the two groups were compared, and the incidence of adverse reactions in patients was closely monitored. Results The total effective rate of observation group was higher than that of control group (P <0.05). Before treatment, there was no significant difference in neurological deficit between the two groups (P> 0.05). The neurological impairment in the observation group was significantly improved after 2 weeks of treatment and the improvement was better than that in the control group (P <0.05) ). The incidence of adverse reactions in observation group was lower than that in control group (P <0.05). Conclusion On the basis of routine drug therapy, the combination of edaravone and ginkgo biloba in patients with acute cerebral infarction is a feasible, effective and economical treatment. The clinical curative effect is definite, which can effectively improve the neurological function of patients and is safe High sex.